Alimera Sciences To Release Second Quarter 2014 Results

           Alimera Sciences To Release Second Quarter 2014 Results

PR Newswire

ATLANTA, July 24, 2014

ATLANTA, July 24, 2014 /PRNewswire/ --Alimera Sciences, Inc. (NASDAQ: ALIM)
("Alimera"), a biopharmaceutical company that specializes in the research,
development and commercialization of prescription ophthalmic pharmaceuticals,
today announced that it will release its second quarter of fiscal year 2014
financial results after the market close on Thursday, August 7, 2014. An
investor conference call will follow on the same day at 4:30 p.m. ET.

The conference call will be hosted by Dan Myers, President and Chief Executive
Officer, and Rick Eiswirth, Chief Operating Officer and Chief Financial
Officer.

To participate in the call, please dial (877) 369-6586 (U.S. and Canada) or
(253) 237-1165 (international). A live webcast will be available on the
Investor Relations section of the corporate website at
http://www.alimerasciences.com.

A replay of the conference call will be available beginning August 7, 2014 at
7:30 p.m. ET and ending on August 14, 2014 by dialing (855) 859-2056 (U.S. and
Canada) or (404) 537-3406 (international), Conference ID Number: 77034836. A
replay of the webcast will also be available on the corporate website.

About Alimera Sciences, Inc.

Alimera Sciences, Inc., headquartered in Alpharetta, Georgia, is a
biopharmaceutical company that specializes in the research, development and
commercialization of prescription ophthalmic pharmaceuticals. Alimera's
European operations are conducted from London by its wholly-owned subsidiary,
Alimera Sciences Limited.

Investor Contact:
ICR, LLC
John Mills
310-954-1105
John.Mills@icrinc.com

SOURCE Alimera Sciences, Inc.

Website: http://www.alimerasciences.com
 
Press spacebar to pause and continue. Press esc to stop.